{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T13:34:27Z","timestamp":1787578467123,"version":"build-2736575974"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"vor","delay-in-days":70,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004479","name":"Natural Science Foundation of Jiangxi Province","doi-asserted-by":"crossref","award":["20232BAB216037"],"award-info":[{"award-number":["20232BAB216037"]}],"id":[{"id":"10.13039\/501100004479","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-026-02205-4","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T08:16:15Z","timestamp":1781511375000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dissecting PCD-driven molecular landscapes in AML: a multi-omic framework for prognostication and therapeutic targeting"],"prefix":"10.1007","volume":"26","author":[{"given":"Jing","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangmin","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaozhong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liuqing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zanwei","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linlin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangyao","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,15]]},"reference":[{"key":"2205_CR1","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3322\/caac.21873","volume":"75","author":"HM Kantarjian","year":"2025","unstructured":"Kantarjian HM, et al. Acute myeloid leukemia management and research in 2025. Cancer J Clin. 2025;75:46\u201367. https:\/\/doi.org\/10.3322\/caac.21873.","journal-title":"Cancer J Clin"},{"key":"2205_CR2","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1001\/jamaoncol.2024.2662","volume":"10","author":"S Venugopal","year":"2024","unstructured":"Venugopal S, Sekeres MA. Contemporary Management of Acute Myeloid Leukemia: A Review. JAMA Oncol. 2024;10:1417\u201325. https:\/\/doi.org\/10.1001\/jamaoncol.2024.2662.","journal-title":"JAMA Oncol"},{"key":"2205_CR3","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1056\/NEJMoa1516192","volume":"374","author":"E Papaemmanuil","year":"2016","unstructured":"Papaemmanuil E, et al. Genomic Classification and Prognosis in Acute Myeloid Leukemia. N Engl J Med. 2016;374:2209\u201321. https:\/\/doi.org\/10.1056\/NEJMoa1516192.","journal-title":"N Engl J Med"},{"key":"2205_CR4","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s10020-024-00861-4","volume":"30","author":"X Tan","year":"2024","unstructured":"Tan X, et al. The dual role of FSP1 in programmed cell death: resisting ferroptosis in the cell membrane and promoting necroptosis in the nucleus of THP-1 cells. Mol Med (Cambridge Mass). 2024;30:102. https:\/\/doi.org\/10.1186\/s10020-024-00861-4.","journal-title":"Mol Med (Cambridge Mass)"},{"key":"2205_CR5","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ccell.2016.06.002","volume":"30","author":"U H\u00f6ckendorf","year":"2016","unstructured":"H\u00f6ckendorf U, et al. RIPK3 Restricts Myeloid Leukemogenesis by Promoting Cell Death and Differentiation of Leukemia Initiating Cells. Cancer Cell. 2016;30:75\u201391. https:\/\/doi.org\/10.1016\/j.ccell.2016.06.002.","journal-title":"Cancer Cell"},{"key":"2205_CR6","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1038\/s41591-018-0082-y","volume":"24","author":"DC Johnson","year":"2018","unstructured":"Johnson DC, et al. DPP8\/DPP9 inhibitor-induced pyroptosis for treatment of acute myeloid leukemia. Nat Med. 2018;24:1151\u20136. https:\/\/doi.org\/10.1038\/s41591-018-0082-y.","journal-title":"Nat Med"},{"key":"2205_CR7","doi-asserted-by":"publisher","first-page":"144889","DOI":"10.1016\/j.gene.2020.144889","volume":"755","author":"Y Du","year":"2020","unstructured":"Du Y, et al. Targeting ferroptosis contributes to ATPR-induced AML differentiation via ROS-autophagy-lysosomal pathway. Gene. 2020;755:144889. https:\/\/doi.org\/10.1016\/j.gene.2020.144889.","journal-title":"Gene"},{"key":"2205_CR8","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1080\/15548627.2016.1245263","volume":"13","author":"S Piya","year":"2017","unstructured":"Piya S, Andreeff M, Borthakur G. Targeting autophagy to overcome chemoresistance in acute myelogenous leukemia. Autophagy. 2017;13:214\u20135. https:\/\/doi.org\/10.1080\/15548627.2016.1245263.","journal-title":"Autophagy"},{"key":"2205_CR9","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/s41586-018-0623-z","volume":"562","author":"JW Tyner","year":"2018","unstructured":"Tyner JW, et al. Functional genomic landscape of acute myeloid leukaemia. Nature. 2018;562:526\u201331. https:\/\/doi.org\/10.1038\/s41586-018-0623-z.","journal-title":"Nature"},{"key":"2205_CR10","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1053\/j.seminhematol.2018.08.001","volume":"56","author":"SF Cai","year":"2019","unstructured":"Cai SF, Levine RL. Genetic and epigenetic determinants of AML pathogenesis. Semin Hematol. 2019;56:84\u20139. https:\/\/doi.org\/10.1053\/j.seminhematol.2018.08.001.","journal-title":"Semin Hematol"},{"key":"2205_CR11","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.ccell.2017.11.003","volume":"32","author":"R Pan","year":"2017","unstructured":"Pan R, et al. Synthetic Lethality of Combined Bcl-2 Inhibition and p53 Activation in AML: Mechanisms and Superior Antileukemic Efficacy. Cancer Cell. 2017;32:748\u2013e760746. https:\/\/doi.org\/10.1016\/j.ccell.2017.11.003.","journal-title":"Cancer Cell"},{"key":"2205_CR12","doi-asserted-by":"publisher","first-page":"101195","DOI":"10.1016\/j.blre.2024.101195","volume":"65","author":"DJ Fowler-Shorten","year":"2024","unstructured":"Fowler-Shorten DJ, Hellmich C, Markham M, Bowles KM, Rushworth SA. BCL-2 inhibition in haematological malignancies: Clinical application and complications. Blood Rev. 2024;65:101195. https:\/\/doi.org\/10.1016\/j.blre.2024.101195.","journal-title":"Blood Rev"},{"key":"2205_CR13","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1007\/s10495-013-0842-6","volume":"18","author":"C Hinterleitner","year":"2013","unstructured":"Hinterleitner C, et al. Rac1 signaling protects monocytic AML cells expressing the MLL-AF9 oncogene from caspase-mediated apoptotic death. Apoptosis: Int J Program cell death. 2013;18:963\u201379. https:\/\/doi.org\/10.1007\/s10495-013-0842-6.","journal-title":"Apoptosis: Int J Program cell death"},{"key":"2205_CR14","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/s41375-023-02117-2","volume":"38","author":"H Akiyama","year":"2024","unstructured":"Akiyama H, et al. Mitochondrial regulation of GPX4 inhibition-mediated ferroptosis in acute myeloid leukemia. Leukemia. 2024;38:729\u201340. https:\/\/doi.org\/10.1038\/s41375-023-02117-2.","journal-title":"Leukemia"},{"key":"2205_CR15","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.freeradbiomed.2024.01.005","volume":"213","author":"Y Wei","year":"2024","unstructured":"Wei Y, et al. Propionate promotes ferroptosis and apoptosis through mitophagy and ACSL4-mediated ferroptosis elicits anti-leukemia immunity. Free Radic Biol Med. 2024;213:36\u201351. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2024.01.005.","journal-title":"Free Radic Biol Med"},{"key":"2205_CR16","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1002\/ijc.32246","volume":"145","author":"LK Hillert","year":"2019","unstructured":"Hillert LK, et al. Targeting RIPK1 in AML cells carrying FLT3-ITD. Int J Cancer. 2019;145:1558\u201369. https:\/\/doi.org\/10.1002\/ijc.32246.","journal-title":"Int J Cancer"},{"key":"2205_CR17","doi-asserted-by":"publisher","first-page":"eadi1782","DOI":"10.1126\/sciadv.adi1782","volume":"10","author":"S Zhu","year":"2024","unstructured":"Zhu S, et al. RIPK3 deficiency blocks R-2-hydroxyglutarate-induced necroptosis in IDH-mutated AML cells. Sci Adv. 2024;10:eadi1782. https:\/\/doi.org\/10.1126\/sciadv.adi1782.","journal-title":"Sci Adv"},{"key":"2205_CR18","doi-asserted-by":"publisher","first-page":"D711","DOI":"10.1093\/nar\/gky964","volume":"47","author":"A Athar","year":"2019","unstructured":"Athar A, et al. ArrayExpress update - from bulk to single-cell expression data. Nucleic Acids Res. 2019;47:D711\u20135. https:\/\/doi.org\/10.1093\/nar\/gky964.","journal-title":"Nucleic Acids Res"},{"key":"2205_CR19","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1186\/s12967-023-04468-x","volume":"21","author":"H Qin","year":"2023","unstructured":"Qin H, et al. Integrated machine learning survival framework develops a prognostic model based on inter-crosstalk definition of mitochondrial function and cell death patterns in a large multicenter cohort for lower-grade glioma. J translational Med. 2023;21:588. https:\/\/doi.org\/10.1186\/s12967-023-04468-x.","journal-title":"J translational Med"},{"key":"2205_CR20","doi-asserted-by":"publisher","first-page":"106936","DOI":"10.1016\/j.ijsu.2022.106936","volume":"107","author":"Y Zou","year":"2022","unstructured":"Zou Y, et al. Leveraging diverse cell-death patterns to predict the prognosis and drug sensitivity of triple-negative breast cancer patients after surgery. Int J Surg (London England). 2022;107:106936. https:\/\/doi.org\/10.1016\/j.ijsu.2022.106936.","journal-title":"Int J Surg (London England)"},{"key":"2205_CR21","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/j.cell.2019.01.031","volume":"176","author":"P van Galen","year":"2019","unstructured":"van Galen P, et al. Single-Cell RNA-Seq Reveals AML Hierarchies Relevant to Disease Progression and Immunity. Cell. 2019;176:1265\u2013e12811224. https:\/\/doi.org\/10.1016\/j.cell.2019.01.031.","journal-title":"Cell"},{"key":"2205_CR22","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16:284\u20137. https:\/\/doi.org\/10.1089\/omi.2011.0118.","journal-title":"OMICS"},{"key":"2205_CR23","doi-asserted-by":"publisher","unstructured":"H\u00e4nzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics. 2013;14. https:\/\/doi.org\/10.1186\/1471-2105-14-7.","DOI":"10.1186\/1471-2105-14-7"},{"key":"2205_CR24","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"A Newman","year":"2015","unstructured":"Newman A, et al. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12:453\u20137. https:\/\/doi.org\/10.1038\/nmeth.3337.","journal-title":"Nat Methods"},{"key":"2205_CR25","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1093\/bioinformatics\/btq170","volume":"26","author":"M Wilkerson","year":"2010","unstructured":"Wilkerson M, Hayes D. ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking. Bioinf (Oxford England). 2010;26:1572\u20133. https:\/\/doi.org\/10.1093\/bioinformatics\/btq170.","journal-title":"Bioinf (Oxford England)"},{"key":"2205_CR26","doi-asserted-by":"publisher","first-page":"4033","DOI":"10.1158\/1078-0432.Ccr-22-1618","volume":"28","author":"P Jin","year":"2022","unstructured":"Jin P, et al. Large-Scale In Vitro and In Vivo CRISPR-Cas9 Knockout Screens Identify a 16-Gene Fitness Score for Improved Risk Assessment in Acute Myeloid Leukemia. Clin Cancer Res. 2022;28:4033\u201344. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-22-1618.","journal-title":"Clin Cancer Res"},{"key":"2205_CR27","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/nature20598","volume":"540","author":"SW Ng","year":"2016","unstructured":"Ng SW, et al. A 17-gene stemness score for rapid determination of risk in acute leukaemia. Nature. 2016;540:433\u20137. https:\/\/doi.org\/10.1038\/nature20598.","journal-title":"Nature"},{"key":"2205_CR28","doi-asserted-by":"publisher","first-page":"5322","DOI":"10.1182\/bloodadvances.2020002042","volume":"4","author":"A Nehme","year":"2020","unstructured":"Nehme A, et al. Horizontal meta-analysis identifies common deregulated genes across AML subgroups providing a robust prognostic signature. Blood Adv. 2020;4:5322\u201335. https:\/\/doi.org\/10.1182\/bloodadvances.2020002042.","journal-title":"Blood Adv"},{"key":"2205_CR29","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1002\/ajh.26309","volume":"96","author":"Z Chen","year":"2021","unstructured":"Chen Z, et al. A novel 4-mRNA signature predicts the overall survival in acute myeloid leukemia. Am J Hematol. 2021;96:1385\u201395. https:\/\/doi.org\/10.1002\/ajh.26309.","journal-title":"Am J Hematol"},{"key":"2205_CR30","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1093\/neuonc\/noac033","volume":"24","author":"T Liu","year":"2022","unstructured":"Liu T, et al. Ferroptosis, as the most enriched programmed cell death process in glioma, induces immunosuppression and immunotherapy resistance. Neurooncology. 2022;24:1113\u201325. https:\/\/doi.org\/10.1093\/neuonc\/noac033.","journal-title":"Neurooncology"},{"key":"2205_CR31","doi-asserted-by":"publisher","unstructured":"Du F, et al. Targeting novel regulated cell death: disulfidptosis in cancer immunotherapy with immune checkpoint inhibitors. Biomark Res. 2025;13. https:\/\/doi.org\/10.1186\/s40364-025-00748-4.","DOI":"10.1186\/s40364-025-00748-4"},{"key":"2205_CR32","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1182\/blood.2022016322","volume":"142","author":"CS Tremblay","year":"2023","unstructured":"Tremblay CS, et al. STAT5 activation promotes progression and chemotherapy resistance in early T-cell precursor acute lymphoblastic leukemia. Blood. 2023;142:274\u201389. https:\/\/doi.org\/10.1182\/blood.2022016322.","journal-title":"Blood"},{"key":"2205_CR33","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1007\/s00432-024-05676-8","volume":"150","author":"F Li","year":"2024","unstructured":"Li F, Miao J, Liu R, Zhang R, He A. Pan-cancer analysis of DDIT4 identifying its prognostic value and function in acute myeloid leukemia. J Cancer Res Clin Oncol. 2024;150:144. https:\/\/doi.org\/10.1007\/s00432-024-05676-8.","journal-title":"J Cancer Res Clin Oncol"},{"key":"2205_CR34","doi-asserted-by":"publisher","unstructured":"Garciaz S, Hospital MA, Collette Y, Vey N. Venetoclax Resistance in Acute Myeloid Leukemia. Cancers (Basel). 2024;16. https:\/\/doi.org\/10.3390\/cancers16061091.","DOI":"10.3390\/cancers16061091"},{"key":"2205_CR35","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.ccr.2009.06.007","volume":"16","author":"KI Oravecz-Wilson","year":"2009","unstructured":"Oravecz-Wilson KI, et al. Persistence of leukemia-initiating cells in a conditional knockin model of an imatinib-responsive myeloproliferative disorder. Cancer Cell. 2009;16:137\u201348. https:\/\/doi.org\/10.1016\/j.ccr.2009.06.007.","journal-title":"Cancer Cell"},{"key":"2205_CR36","doi-asserted-by":"publisher","first-page":"45960","DOI":"10.1038\/srep45960","volume":"7","author":"J Wang","year":"2017","unstructured":"Wang J, et al. Prognostic significance of huntingtin interacting protein 1 expression on patients with acute myeloid leukemia. Sci Rep. 2017;7:45960. https:\/\/doi.org\/10.1038\/srep45960.","journal-title":"Sci Rep"},{"key":"2205_CR37","doi-asserted-by":"publisher","first-page":"188394","DOI":"10.1016\/j.bbcan.2020.188394","volume":"1874","author":"H Xu","year":"2020","unstructured":"Xu H, Zhou S, Tang Q, Xia H, Bi F. Cholesterol metabolism: New functions and therapeutic approaches in cancer. Biochim Biophys Acta Rev Cancer. 2020;1874:188394. https:\/\/doi.org\/10.1016\/j.bbcan.2020.188394.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"2205_CR38","doi-asserted-by":"publisher","first-page":"E4","DOI":"10.1002\/ajh.24925","volume":"93","author":"V Izzi","year":"2018","unstructured":"Izzi V, et al. Vanin 1 (VNN1) levels predict poor outcome in acute myeloid leukemia. Am J Hematol. 2018;93:E4\u20137. https:\/\/doi.org\/10.1002\/ajh.24925.","journal-title":"Am J Hematol"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-026-02205-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-026-02205-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-026-02205-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T13:09:31Z","timestamp":1787576971000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-026-02205-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,15]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2205"],"URL":"https:\/\/doi.org\/10.1007\/s10238-026-02205-4","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,15]]},"assertion":[{"value":"18 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of the Second Affiliated Hospital of Nanchang University.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"305"}}